L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes.
TL;DR: OLM delayed the onset of microalbuminuria, as well as the ECG signs of cardiac structural adaptation in type 2 diabetes, which was not explained by the differences in blood pressure control.
Journal ArticleDOI
The Meaning of Cardiometabolic Risk in Hypertensive Patients
TL;DR: Cardiometabolic risk is diagnosed by the identification of an enhanced waist circumference accompanied by the alterations in lipid profile quoted above.
Journal ArticleDOI
Dopaminergic control of prolactin and blood pressure.
Rafael García-Robles,Luis M. Ruilope,Hurtado A,Jose L. Rodicio,Joaquín Mariano Mantecón Sancho +4 more
Journal ArticleDOI
Intradialytic neuromuscular electrical stimulation improves functional capacity and muscle strength in people receiving haemodialysis: a systematic review
Pedro L. Valenzuela,Javier S. Morales,Luis M. Ruilope,Pedro de la Villa,Alejandro Santos-Lozano,Alejandro Lucia +5 more
TL;DR: NMES is safe, practical and effective for improving functional capacity and muscle strength in haemodialysis patients and was estimated to be beneficial for several domains of quality of life in several studies, although most of these estimates were imprecise.
Journal ArticleDOI
Renal participation in cardiovascular risk in essential hypertension.
Luis M. Ruilope,Jose L. Rodicio +1 more
TL;DR: The aim of this short review is to present the evidence supporting the existence of mild renal insufficiency in hypertensive patients, but also to show the association of this disorder with a very significant increment in global cardiovascular risk.